Neuraxis, Inc.
$6.94
$1.24 (+21.75%)
$6.14Day Range$7.74
Key Statistics
Market Cap
$71.58M
Shares Outstanding
12.6M
Primary Exchange
XASE
Currency
USD
Type
CS
IPO Date
Aug 9, 2023
Round Lot
100
Locale
US
Trading Data
Day Open
$6.14
Day High
$7.74
Day Low
$6.14
Volume
1.08M
VWAP
$7.04
Prev Close
$5.70
Transactions
--
Acc. Volume
--
About Neuraxis, Inc.
Neuraxis Inc is a growth-stage medical technology company focused on neuromodulation therapies for chronic and debilitating conditions in the gastrointestinal (GI) digestive system, specifically from disorders of the gut-brain interaction (DGBIs) in pediatrics and adults. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUSSIC 384524 employees11611 N. MERIDIAN ST, CARMEL, IN, 46032(812) 689-0791IPO Aug 9, 2023US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001933567
- Composite FIGI
- BBG01C9N12C3
- Share Class FIGI
- BBG01C9N1368
- Ticker Root
- NRXS
- SIC Code
- 3845
About Neuraxis, Inc. (NRXS) Stock
Neuraxis, Inc. (NRXS) closed the 2026-09-16 session at $6.94, up 21.75% versus the previous close (+1.24). The stock opened at $6.14 and traded between $6.14 and $7.74 during that session. Session trading volume was 1.1M shares. The volume-weighted average price (VWAP) is $7.04.
Neuraxis Inc is a growth-stage medical technology company focused on neuromodulation therapies for chronic and debilitating conditions in the gastrointestinal (GI) digestive system, specifically from disorders of the gut-brain interaction (DGBIs) in pediatrics and adults. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).
Neuraxis, Inc. has a market capitalization of $71.6 million. The company operates in the ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS industry classification. NRXS is listed on the XASE exchange. The company employs approximately 24 people. Neuraxis, Inc. is headquartered in CARMEL, IN. The recorded listing date is 2023-08-09.
On this page you can find market NRXS stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS sector.